Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1997 May 1;16(9):2408–2419. doi: 10.1093/emboj/16.9.2408

An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

P D Aplan 1, C A Jones 1, D S Chervinsky 1, X Zhao 1, M Ellsworth 1, C Wu 1, E A McGuire 1, K W Gross 1
PMCID: PMC1169841  PMID: 9171354

Abstract

The product of the scl (also called tal-1 or TCL5) gene is a basic domain, helix-loop-helix (bHLH) transcription factor required for the development of hematopoietic cells. Additionally, scl gene disruption and dysregulation, by either chromosomal translocations or a site-specific interstitial deletion whereby 5' regulatory elements of the sil gene become juxtaposed to the body of the scl gene, is associated with T-cell acute lymphoblastic leukemia (ALL) and T-cell lymphoblastic lymphoma. Here we show that an inappropriately expressed scl protein, driven by sil regulatory elements, can cause aggressive T-cell malignancies in collaboration with a misexpressed LMO1 protein, thus recapitulating the situation seen in a subset of human T-cell ALL. Moreover, we show that inappropriately expressed scl can interfere with the development of other tissues derived from mesoderm. Lastly, we show that an scl construct lacking the scl transactivation domain collaborates with misexpressed LMO1, demonstrating that the scl transactivation domain is dispensable for oncogenesis, and supporting the hypothesis that the scl gene product exerts its oncogenic action through a dominant-negative mechanism.

Full Text

The Full Text of this article is available as a PDF (437.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aplan P. D., Begley C. G., Bertness V., Nussmeier M., Ezquerra A., Coligan J., Kirsch I. R. The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol. 1990 Dec;10(12):6426–6435. doi: 10.1128/mcb.10.12.6426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aplan P. D., Lombardi D. P., Ginsberg A. M., Cossman J., Bertness V. L., Kirsch I. R. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science. 1990 Dec 7;250(4986):1426–1429. doi: 10.1126/science.2255914. [DOI] [PubMed] [Google Scholar]
  3. Aplan P. D., Lombardi D. P., Kirsch I. R. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia. Mol Cell Biol. 1991 Nov;11(11):5462–5469. doi: 10.1128/mcb.11.11.5462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Begley C. G., Aplan P. D., Denning S. M., Haynes B. F., Waldmann T. A., Kirsch I. R. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10128–10132. doi: 10.1073/pnas.86.24.10128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bernard O., Lecointe N., Jonveaux P., Souyri M., Mauchauffé M., Berger R., Larsen C. J., Mathieu-Mahul D. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene. Oncogene. 1991 Aug;6(8):1477–1488. [PubMed] [Google Scholar]
  6. Boehm T., Foroni L., Kaneko Y., Perutz M. F., Rabbitts T. H. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4367–4371. doi: 10.1073/pnas.88.10.4367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown L., Cheng J. T., Chen Q., Siciliano M. J., Crist W., Buchanan G., Baer R. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 1990 Oct;9(10):3343–3351. doi: 10.1002/j.1460-2075.1990.tb07535.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carroll A. J., Crist W. M., Link M. P., Amylon M. D., Pullen D. J., Ragab A. H., Buchanan G. R., Wimmer R. S., Vietti T. J. The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990 Sep 15;76(6):1220–1224. [PubMed] [Google Scholar]
  9. Cheng J. T., Hsu H. L., Hwang L. Y., Baer R. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene. 1993 Mar;8(3):677–683. [PubMed] [Google Scholar]
  10. Collazo-Garcia N., Scherer P., Aplan P. D. Cloning and characterization of a murine SIL gene. Genomics. 1995 Dec 10;30(3):506–513. doi: 10.1006/geno.1995.1271. [DOI] [PubMed] [Google Scholar]
  11. Cuypers H. T., Selten G., Quint W., Zijlstra M., Maandag E. R., Boelens W., van Wezenbeek P., Melief C., Berns A. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell. 1984 May;37(1):141–150. doi: 10.1016/0092-8674(84)90309-x. [DOI] [PubMed] [Google Scholar]
  12. Elwood N. J., Begley C. G. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia. Cell Growth Differ. 1995 Jan;6(1):19–25. [PubMed] [Google Scholar]
  13. Finger L. R., Kagan J., Christopher G., Kurtzberg J., Hershfield M. S., Nowell P. C., Croce C. M. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5039–5043. doi: 10.1073/pnas.86.13.5039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hatano M., Roberts C. W., Minden M., Crist W. M., Korsmeyer S. J. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science. 1991 Jul 5;253(5015):79–82. doi: 10.1126/science.1676542. [DOI] [PubMed] [Google Scholar]
  15. Hofmann T. J., Cole M. D. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation. Oncogene. 1996 Aug 1;13(3):617–624. [PubMed] [Google Scholar]
  16. Hsu H. L., Cheng J. T., Chen Q., Baer R. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol. 1991 Jun;11(6):3037–3042. doi: 10.1128/mcb.11.6.3037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hsu H. L., Huang L., Tsan J. T., Funk W., Wright W. E., Hu J. S., Kingston R. E., Baer R. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol. 1994 Feb;14(2):1256–1265. doi: 10.1128/mcb.14.2.1256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hsu H. L., Wadman I., Tsan J. T., Baer R. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5947–5951. doi: 10.1073/pnas.91.13.5947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hwang L. Y., Siegelman M., Davis L., Oppenheimer-Marks N., Baer R. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. Oncogene. 1993 Nov;8(11):3043–3046. [PubMed] [Google Scholar]
  20. Kimmel C. A., Trammell C. A rapid procedure for routine double staining of cartilage and bone in fetal and adult animals. Stain Technol. 1981 Sep;56(5):271–273. doi: 10.3109/10520298109067325. [DOI] [PubMed] [Google Scholar]
  21. Larson R. C., Lavenir I., Larson T. A., Baer R., Warren A. J., Wadman I., Nottage K., Rabbitts T. H. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 1996 Mar 1;15(5):1021–1027. [PMC free article] [PubMed] [Google Scholar]
  22. Mahajan M. A., Park S. T., Sun X. H. Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins. Oncogene. 1996 Jun 6;12(11):2343–2350. [PubMed] [Google Scholar]
  23. Murre C., McCaw P. S., Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 1989 Mar 10;56(5):777–783. doi: 10.1016/0092-8674(89)90682-x. [DOI] [PubMed] [Google Scholar]
  24. Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F. W., Orkin S. H. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 1996 Jul 12;86(1):47–57. doi: 10.1016/s0092-8674(00)80076-8. [DOI] [PubMed] [Google Scholar]
  25. Pulford K., Lecointe N., Leroy-Viard K., Jones M., Mathieu-Mahul D., Mason D. Y. Expression of TAL-1 proteins in human tissues. Blood. 1995 Feb 1;85(3):675–684. [PubMed] [Google Scholar]
  26. Robb L., Elwood N. J., Elefanty A. G., Köntgen F., Li R., Barnett L. D., Begley C. G. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 1996 Aug 15;15(16):4123–4129. [PMC free article] [PubMed] [Google Scholar]
  27. Robb L., Rasko J. E., Bath M. L., Strasser A., Begley C. G. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene. 1995 Jan 5;10(1):205–209. [PubMed] [Google Scholar]
  28. Royer-Pokora B., Loos U., Ludwig W. D. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene. 1991 Oct;6(10):1887–1893. [PubMed] [Google Scholar]
  29. Schenker T., Lach C., Kessler B., Calderara S., Trueb B. A novel GTP-binding protein which is selectively repressed in SV40 transformed fibroblasts. J Biol Chem. 1994 Oct 14;269(41):25447–25453. [PubMed] [Google Scholar]
  30. Shivdasani R. A., Mayer E. L., Orkin S. H. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 1995 Feb 2;373(6513):432–434. doi: 10.1038/373432a0. [DOI] [PubMed] [Google Scholar]
  31. Sánchez-García I., Rabbitts T. H. Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7869–7873. doi: 10.1073/pnas.91.17.7869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Voronova A. F., Lee F. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5952–5956. doi: 10.1073/pnas.91.13.5952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wadman I. A., Hsu H. L., Cobb M. H., Baer R. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain. Oncogene. 1994 Dec;9(12):3713–3716. [PubMed] [Google Scholar]
  35. Wadman I., Li J., Bash R. O., Forster A., Osada H., Rabbitts T. H., Baer R. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 1994 Oct 17;13(20):4831–4839. doi: 10.1002/j.1460-2075.1994.tb06809.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zhuang Y., Cheng P., Weintraub H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol Cell Biol. 1996 Jun;16(6):2898–2905. doi: 10.1128/mcb.16.6.2898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. van Lohuizen M., Verbeek S., Krimpenfort P., Domen J., Saris C., Radaszkiewicz T., Berns A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell. 1989 Feb 24;56(4):673–682. doi: 10.1016/0092-8674(89)90589-8. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES